Alaunos Therapeutics, Inc. Lessor, Operating Lease, Payment to be Received, Year Two
Alaunos Therapeutics, Inc. (TCRT) had Lessor, Operating Lease, Payment to be Received, Year Two of $200.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity
us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears · last filed 2023-03-07
- 2022-12-31: Lessor, Operating Lease, Payment to be Received, Year Two $200.00K.
| Period end | Lessor, Operating Lease, Payment to be Received, Year Two |
|---|---|
| 2022-12-31 | $200.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |